341 related articles for article (PubMed ID: 19412100)
1. New selective estrogen and androgen receptor modulators.
Clarke BL; Khosla S
Curr Opin Rheumatol; 2009 Jul; 21(4):374-9. PubMed ID: 19412100
[TBL] [Abstract][Full Text] [Related]
2. Modulators of androgen and estrogen receptor activity.
Clarke BL; Khosla S
Crit Rev Eukaryot Gene Expr; 2010; 20(4):275-94. PubMed ID: 21395502
[TBL] [Abstract][Full Text] [Related]
3. The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practice.
Maximov PY; Lee TM; Jordan VC
Curr Clin Pharmacol; 2013 May; 8(2):135-55. PubMed ID: 23062036
[TBL] [Abstract][Full Text] [Related]
4. The selective estrogen receptor modulators in breast cancer prevention.
Li F; Dou J; Wei L; Li S; Liu J
Cancer Chemother Pharmacol; 2016 May; 77(5):895-903. PubMed ID: 26787504
[TBL] [Abstract][Full Text] [Related]
5. The use of selective estrogen receptor modulators and selective estrogen receptor down-regulators in breast cancer.
Howell SJ; Johnston SR; Howell A
Best Pract Res Clin Endocrinol Metab; 2004 Mar; 18(1):47-66. PubMed ID: 14687597
[TBL] [Abstract][Full Text] [Related]
6. Selective Androgen Receptor Modulators: Current Knowledge and Clinical Applications.
Solomon ZJ; Mirabal JR; Mazur DJ; Kohn TP; Lipshultz LI; Pastuszak AW
Sex Med Rev; 2019 Jan; 7(1):84-94. PubMed ID: 30503797
[TBL] [Abstract][Full Text] [Related]
7. Endometrial safety: a key hurdle for selective estrogen receptor modulators in development.
Pinkerton JV; Goldstein SR
Menopause; 2010; 17(3):642-53. PubMed ID: 20107426
[TBL] [Abstract][Full Text] [Related]
8. Selective estrogen receptor modulation and reduction in risk of breast cancer, osteoporosis, and coronary heart disease.
Jordan VC; Gapstur S; Morrow M
J Natl Cancer Inst; 2001 Oct; 93(19):1449-57. PubMed ID: 11584060
[TBL] [Abstract][Full Text] [Related]
9. Selective estrogen receptor modulators: mechanism of action and clinical experience. Focus on raloxifene.
Thiebaud D; Secrest RJ
Reprod Fertil Dev; 2001; 13(4):331-6. PubMed ID: 11800172
[TBL] [Abstract][Full Text] [Related]
10. Potential of selective estrogen receptor modulators as treatments and preventives of breast cancer.
Peng J; Sengupta S; Jordan VC
Anticancer Agents Med Chem; 2009 Jun; 9(5):481-99. PubMed ID: 19519291
[TBL] [Abstract][Full Text] [Related]
11. Endocrine manipulation in advanced breast cancer: recent advances with SERM therapies.
Johnston SR
Clin Cancer Res; 2001 Dec; 7(12 Suppl):4376s-4387s; discussion 4411s-4412s. PubMed ID: 11916228
[TBL] [Abstract][Full Text] [Related]
12. [Selective estrogen receptor modulators (SERMs) in the practice].
Nagykálnai T
Magy Onkol; 2002; 46(2):165-75. PubMed ID: 12202896
[TBL] [Abstract][Full Text] [Related]
13. Gonadal Hormones and Bone.
Yoshida T; Wang J; Stern PH
Handb Exp Pharmacol; 2020; 262():65-91. PubMed ID: 31820173
[TBL] [Abstract][Full Text] [Related]
14. Cell type- and estrogen receptor-subtype specific regulation of selective estrogen receptor modulator regulatory elements.
Ball LJ; Levy N; Zhao X; Griffin C; Tagliaferri M; Cohen I; Ricke WA; Speed TP; Firestone GL; Leitman DC
Mol Cell Endocrinol; 2009 Feb; 299(2):204-11. PubMed ID: 19059307
[TBL] [Abstract][Full Text] [Related]
15. Estrogen, selective estrogen receptor modulators and now mechanism-specific ligands of the estrogen or androgen receptor?
Khosla S
Trends Pharmacol Sci; 2003 Jun; 24(6):261-3. PubMed ID: 12823947
[TBL] [Abstract][Full Text] [Related]
16. Selective estrogen receptor modulators for postmenopausal osteoporosis: current state of development.
Gennari L; Merlotti D; Valleggi F; Martini G; Nuti R
Drugs Aging; 2007; 24(5):361-79. PubMed ID: 17503894
[TBL] [Abstract][Full Text] [Related]
17. Clinical use of selective estrogen receptor modulators and down regulators with the main focus on breast cancer.
Baumann CK; Castiglione-Gertsch M
Minerva Ginecol; 2009 Dec; 61(6):517-39. PubMed ID: 19942839
[TBL] [Abstract][Full Text] [Related]
18. Selective estrogen receptor modulation: the search for an ideal hormonal therapy for breast cancer.
Dhingra K
Cancer Invest; 2001; 19(6):649-59. PubMed ID: 11486708
[TBL] [Abstract][Full Text] [Related]
19. Lasofoxifene: a new type of selective estrogen receptor modulator for the treatment of osteoporosis.
Gennari L
Drugs Today (Barc); 2006 Jun; 42(6):355-67. PubMed ID: 16845439
[TBL] [Abstract][Full Text] [Related]
20. Selective estrogen receptor modulators.
Haskell SG
South Med J; 2003 May; 96(5):469-76. PubMed ID: 12911186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
